Latest Non-steroidal anti-inflammatory drugs Stories

ROCKVILLE, Md., March 16 /PRNewswire-USNewswire/ -- Patients and clinicians should consider risk factors -- including age, gender, diabetes, blood pressure, cholesterol levels, smoking and risk of gastrointestinal bleeding -- before deciding whether to use aspirin to prevent heart attacks or strokes, according to new recommendations from the U.S. Preventive Services Task Force. These recommendations do not apply to people who have already had a heart attack or stroke. The recommendations...

Less Than One-Half Report Regular Aspirin UseNew results from the Women's Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke. Jacques Rossouw, M.D., chief of the Women's Health Initiative Branch at the National Heart, Lung, and Blood Institute (NHLBI), is available to comment on these findings. NHLBI, part of the National Institutes of Health, funded the...

SOPHIA ANTIPOLIS, France, February 26 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced its financial results for full year 2008 and provided an overview of the development and pre-commercialization activities for naproxcinod, its lead investigational drug for the treatment of the signs and symptoms of osteoarthritis (OA). Michele Garufi, Chief Executive Officer of NicOx, commented: "We believe NicOx has entered 2009 in its strongest strategic position...

SAN FRANCISCO, Feb. 25 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today the Company has enrolled its first subjects in its once-daily topical diclofenac sodium patch Phase III program. The program consists of three randomized, double-blind, placebo-controlled Phase III clinical studies with Cerimon's diclofenac patch. The studies will assess the efficacy and safety of Cerimon's diclofenac patch compared to placebo for the treatment of acute pain caused by mild-to-moderate...

ALLEGAN, Mich., Feb. 20 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that has begun shipping over-the-counter (OTC) Ibuprofen and Diphenhydramine Citrate Tablets, 200/38 mg. The product will be marketed under store brand labels and is comparable to Wyeth Consumer Healthcare's Advil(R) PM tablets, 200/38 mg, indicated as a pain reliever (NSAID)/nighttime sleep-aid. Estimated brand sales for the product for the last 12 months ending September 28, 2008 were...

A new British study finds that taking ibuprofen or aspirin, even in very low doses, might protect against stomach cancer.The research found that those who had taken aspirin at least once during the previous year reduced by 36 percent their chances of developing cancer in the middle or lower parts of the stomach, when compared with those who had taken no aspirin.Taking similar doses of a non-steroidal anti-inflammatory drug (NSAID), such as ibuprofen, reduced the chances of developing stomach...

MENLO PARK, Calif., Feb. 6 /PRNewswire/ -- ROXRO announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for its lead investigational prescription drug candidate, ROX-888, for the management of acute moderate to severe pain. ROX-888 is an intranasal formulation of ketorolac, a non-steroidal anti-inflammatory drug (NSAID), designed to provide ambulatory patients with a convenient, potent, and fast-acting option for acute...

- Strong @Heart Campaign Encourages the 44 Million Women Living with or at Risk of Heart Disease to Become Advocates for Women's Heart Health - WASHINGTON, Feb. 2 /PRNewswire/ -- Heart disease is the #1 killer of women in the U.S.,(i) yet women are still not receiving the same in-hospital treatment that men do for heart attacks and as a result, they may be more likely to die.(ii) In an effort to address this problem, Bayer Healthcare LLC, the makers of Bayer Aspirin, and WomenHeart, the...

New research suggests a dose of aspirin may be able to prevent liver damage caused by paracetamol or heavy drinking.Researchers from Yale University found that aspirin cut death rates in mice given a paracetamol overdose.It is likely that aspirin interferes with a chemical pathway that triggers damaging inflammation within the liver, but the British Liver Trust said it was not yet proven to help humans.In the UK, liver cirrhosis rates have risen in recent years as people drink more alcohol,...

SAN DIEGO, Jan. 8 /PRNewswire/ -- Victory Pharma, Inc., a privately held specialty pharmaceutical company, today announced that it is launching two additional dosage strengths of Naprelan(R) (naproxen sodium) Controlled-Release Tablets. NAPRELAN is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and management of mild to...